Gottschalk, Zachary
Cohen, Stacey A.
Article History
Accepted: 28 May 2024
First Online: 6 June 2024
Declarations
:
: This article does not contain any studies with human or animal subjects performed by any of the authors.
: The authors declare no competing interests.
: Zachary Gottschalk declares no conflict of interest. Stacey A. Cohen has received clinical trial funding (to the institution) from Tempus, Natera, Pfizer, Biomea, and BioNTech; and compensation for service as a consultant/advisory board from Abbvie, Guardant, Agenus, Pfizer, Merck, Regeneron, Taiho, Bayer, Delcath, Eisai; and travel funds from Biomea and Natera.